Avant Garde award for Investigators conducting high risk/high reward research on HIV and Substance Use (or Substance Use Disorders)
This grant supports innovative, high-risk research by creative scientists tackling major challenges in HIV and substance use or substance use disorders, including early-stage investigators.
Funder: National Institutes of Health
Due Dates (Anticipated): August 2026 (Full application deadline, projected)
Funding Amounts: Award size and total funding not yet announced; details expected in official NOFO.
Summary: Supports high-risk, high-reward research on HIV and substance use (or substance use disorders), including early stage investigators.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.
Description
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), intends to launch a funding opportunity to support pioneering, high-risk/high-reward research addressing major challenges at the intersection of HIV and substance use or substance use disorders (SUDs). This program, utilizing the DP1 activity code, aims to fund exceptionally creative scientists—at any career stage, including early stage investigators—who propose transformative, cutting-edge biomedical or behavioral research that could significantly advance the field. The Avant-Garde/Avenir Award is designed to encourage innovative approaches and allow sufficient time for applicants to build collaborations and develop responsive projects. Applications are not yet being accepted; this is a forecasted notice.
